NCT00928421View on ClinicalTrials.gov

An Open-label, Single-dose Pilot Study to Evaluate Varisolve® (Polidocanol Endovenous Microfoam (PEM)) 0.125% [0.2%] for Varicose Veins

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

January 31, 2010

Conditions
Varicose Veins
Interventions
DRUG

Polidocanol Endovenous Microfoam 0.125%

Polidocanol Endovenous Microfoam 0.125%, single dose

Trial Locations (1)

Unknown

Bellevue

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY